Candesant Biomedical
San Francisco
About Candesant Biomedical
Candesant Biomedical develops treatment for excessive sweating and hyperhidrosis. It offers a technology that is based on the principle that alkali metals in contact with water generate energy. The insight was that when the amounts of metal and water are controlled, the result is targeted delivery of energy exactly at the site of the water. Its device is designed to target and inactivate the most active sweat glands. The company was founded in 2016 and is headquartered in San Francisco, California.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $44.1M
- Funding stage: Early Stage Venture
- Last round: Series B (Jun 2023)
- Website: candesant.com
Industries & Categories
Health Care, Medical, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/candesant-biomedical-5214 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.